Vaginal estrogen therapy not linked to cancer recurrence in survivors of endometrial cancer
Medical Xpress
March 4, 2026
Despite the increased incidence of endometrial cancer in younger women, there is limited research regarding the safety of local, low-dose vaginal estrogen therapy (ET) for survivors. A new study suggests that this form of estrogen is not only effective in relieving numerous menopause symptoms but also does not seem to increase a woman's risk of cancer recurrence.
Verticals
healthmedical
Originally published on Medical Xpress on 3/4/2026